Skip to content

Zucara Therapeutics

2 viewers · 30d

Total raised

—

No Form D filings on record

No Form D filings on record
LAST ROUND
N/A
ROUNDS
0
INVESTORS
3
FOUNDED
N/A
HQ
N/A
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
2

AI overview

Updated

Zucara Therapeutics Inc. is a pioneering life sciences company focused on diabetes treatment, specifically dedicated to developing innovative solutions to combat hypoglycemia in individuals with diabetes. Through advanced therapeutics, Zucara aims to improve the quality of life for those affected by insulin-dependent diabetes by providing preventive measures against the potentially dangerous side effects of insulin therapy.

What sets it apart

What distinguishes Zucara is its commitment to developing the first once-daily therapeutic specifically to prevent insulin-induced hypoglycemia, addressing a significant unmet medical need in diabetes management.

Products

1 tracked

ZT-01

Diabetes Therapy

ZT-01 is Zucara Therapeutics' lead drug candidate, designed as a first-in-class treatment specifically aimed at preventing incidents of insulin-induced hypoglycemia. This once-daily therapeutic is geared towards re-establishing normal hormonal responses to glucose levels, thereby enhancing patient safety and therapeutic efficacy.

  • Once-daily administration
  • Inhibits somatostatin to regulate glucagon response
  • Targeted towards Type 1 and Type 2 diabetes patients
  • Focus on preventing nocturnal hypoglycemia

Links

WebsiteSEC EDGAR filings